Literature DB >> 36239103

Comparative co-expression analysis of RNA-Seq transcriptome revealing key genes, miRNA and transcription factor in distinct metabolic pathways in diabetic nerve, eye, and kidney disease.

Veeran Kutty Subaida Shafna Asmy1, Jeyakumar Natarajan1.   

Abstract

Diabetes and its related complications are associated with long term damage and failure of various organ systems. The microvascular complications of diabetes considered in this study are diabetic retinopathy, diabetic neuropathy, and diabetic nephropathy. The aim is to identify the weighted co-expressed and differentially expressed genes (DEGs), major pathways, and their miRNA, transcription factors (TFs) and drugs interacting in all the three conditions. The primary goal is to identify vital DEGs in all the three conditions. The overlapped five genes (AKT1, NFKB1, MAPK3, PDPK1, and TNF) from the DEGs and the co-expressed genes were defined as key genes, which differentially expressed in all the three cases. Then the protein-protein interaction network and gene set linkage analysis (GSLA) of key genes was performed. GSLA, gene ontology, and pathway enrichment analysis of the key genes elucidates nine major pathways in diabetes. Subsequently, we constructed the miRNA-gene and transcription factorgene regulatory network of the five gene of interest in the nine major pathways were studied. hsa-mir-34a-5p, a major miRNA that interacted with all the five genes. RELA, FOXO3, PDX1 and SREBF1 were the TFs interacting with the major five gene of interest. Finally, drug-gene interaction network elucidates five potential drugs to treat the genes of interest. This research reveals biomarker genes, miRNA, TFs, and therapeutic drugs in the key signaling pathways, which may help us, understand the processes of all three secondary microvascular problems and aid in disease detection and management.

Entities:  

Keywords:  RNA-Seq transcriptome; co-expression analysis; diabetes nephropathy; diabetes neuropathy; diabetes retinopathy; microvascular complication

Year:  2022        PMID: 36239103      PMCID: PMC9576479          DOI: 10.5808/gi.22029

Source DB:  PubMed          Journal:  Genomics Inform        ISSN: 1598-866X


  37 in total

1.  Diabetes-related microvascular and macrovascular diseases in the physical therapy setting.

Authors:  W Todd Cade
Journal:  Phys Ther       Date:  2008-09-18

2.  miRNet-Functional Analysis and Visual Exploration of miRNA-Target Interactions in a Network Context.

Authors:  Yannan Fan; Jianguo Xia
Journal:  Methods Mol Biol       Date:  2018

3.  MicroRNA-34a regulation of endothelial senescence.

Authors:  Takashi Ito; Shusuke Yagi; Munekazu Yamakuchi
Journal:  Biochem Biophys Res Commun       Date:  2010-07-11       Impact factor: 3.575

4.  NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy.

Authors:  Ashutosh Kumar; Shyam S Sharma
Journal:  Biochem Biophys Res Commun       Date:  2010-03-06       Impact factor: 3.575

5.  Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other microvascular complications: multivariate epidemiological analysis based on patient background factors and severity of diabetic neuropathy.

Authors:  N Hotta; R Kawamori; M Fukuda; Y Shigeta
Journal:  Diabet Med       Date:  2012-12       Impact factor: 4.359

6.  FoxO Transcription Factors Are Critical Regulators of Diabetes-Related Muscle Atrophy.

Authors:  Brian T O'Neill; Gourav Bhardwaj; Christie M Penniman; Megan T Krumpoch; Pablo A Suarez Beltran; Katherine Klaus; Kennedy Poro; Mengyao Li; Hui Pan; Jonathan M Dreyfuss; K Sreekumaran Nair; C Ronald Kahn
Journal:  Diabetes       Date:  2018-12-06       Impact factor: 9.461

7.  Clinical correlation of diabetic retinopathy with nephropathy and neuropathy.

Authors:  Deep C Saini; Anju Kochar; Raunaq Poonia
Journal:  Indian J Ophthalmol       Date:  2021-11       Impact factor: 1.848

Review 8.  The possible role of tumor necrosis factor-alpha in diabetic polyneuropathy.

Authors:  Jo Satoh; Soroku Yagihashi; Takayoshi Toyota
Journal:  Exp Diabesity Res       Date:  2003 Apr-Jun

Review 9.  Microvasular and macrovascular complications in diabetes mellitus: Distinct or continuum?

Authors:  Aastha Chawla; Rajeev Chawla; Shalini Jaggi
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug

Review 10.  Alternative mechanisms of miR-34a regulation in cancer.

Authors:  Eva Slabáková; Zoran Culig; Ján Remšík; Karel Souček
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.